sales@nebiolab.com Email Your Inquiry
(203) 361 3780 Speak to Our Scientists
Agile Bioanalysis Services CRO
  • Expertise
    • All Expertise
    • Liquid Chromatography Mass Spectrometry
      • HPLC Method Development Validation
      • Mass Spectrometric Analysis
    • ELISA Method
    • Meso Scale Discovery Assay
    • Luminex Multiplex Assay
    • LI-COR Odyssey Assay
    • PK PD Analysis
    • Method Development, Validation, and Transfer
      • Method Validation
      • Method Development
      • Method Transfer
  • Services
    • All Services
    • Pharmacokinetics (PK) Study
      • Drug Metabolism and Pharmacokinetics (DMPK)
      • ADME Studies
    • Toxicology (Tox) Study
      • Dose Formulation Analysis
    • ADA Assay Immunogenicity Testing
    • Biomarker Testing Services
      • Biomarker Assay List
    • Bioequivalence and Bioavailability Studies
    • Bioanalytical Assay
      • Biochemical Assay
      • Mechanism of Action (MOA) Studies
      • Cell-based Assays
      • Cytotoxicity Assay
  • Solutions
    • All Solutions
    • Bioanalysis
    • GLP Laboratory
    • Clinical CRO
      • Clinical Trial Sample Management and Storage
    • Preclinical CRO
    • Analytical Testing
      • Analytical Quantitation
    • Non-GLP Testing
      • Discovery and Research
      • Cosmetic Testing
  • About Us
    • About Us
    • Overview
    • Why Us?
    • Values
    • Leadership
    • Process
    • Quality and Compliance
    • Facility and Equipment
    • Therapeutic Areas
    • Partners
    • Careers
      • GLP Quality Assurance Manager, Bioanalytical Lab
      • Sr. Scientist, ELISA Immunoassay Bioanalysis
      • Sr. Scientist, LC-MS/MS Bioanalysis – Hamden, CT, USA
      • Associate Scientist, Central Laboratory Services
      • Sr. Scientist – Pharmacokinetics (PK) Studies
      • Content Manager, Scientific and Regulatory Writing
  • Resources
    • Learning Center
    • Blog
    • Case Study
    • News and Events
    • Testimonials
    • Contact Us
  • Request Quote
Agile Bioanalysis Services CRO Request Quote

Expertise

  • All Expertise
    • Liquid Chromatography Mass Spectrometry
      • HPLC Method Development Validation
      • Mass Spectrometric Analysis
    • ELISA Method
      • Meso Scale Discovery Assay
        • Luminex Multiplex Assay
          • LI-COR Odyssey Assay
            • PK PD Analysis
              • Method Development, Validation, and Transfer
                • Method Validation
                • Method Development
                • Method Transfer

              Services

              • All Services
                • Pharmacokinetics (PK) Study
                  • Drug Metabolism and Pharmacokinetics (DMPK)
                  • ADME Studies
                • Toxicology (Tox) Study
                  • Dose Formulation Analysis
                • ADA Assay Immunogenicity Testing
                  • Biomarker Testing Services
                    • Biomarker Assay List
                  • Bioequivalence and Bioavailability Studies
                    • Bioanalytical Assay
                      • Biochemical Assay
                      • Mechanism of Action (MOA) Studies
                      • Cell-based Assays
                      • Cytotoxicity Assay

                    Solutions

                    • All Solutions
                      • Bioanalysis
                        • GLP Laboratory
                          • Clinical CRO
                            • Clinical Trial Sample Management and Storage
                          • Preclinical CRO
                            • Analytical Testing
                              • Analytical Quantitation
                            • Non-GLP Testing
                              • Discovery and Research
                              • Cosmetic Testing

                            About Us

                            • About Us
                              • Overview
                                • Why Us?
                                  • Values
                                    • Leadership
                                      • Process
                                        • Quality and Compliance
                                          • Facility and Equipment
                                            • Therapeutic Areas
                                              • Partners
                                                • Careers
                                                  • GLP Quality Assurance Manager, Bioanalytical Lab
                                                  • Sr. Scientist, ELISA Immunoassay Bioanalysis
                                                  • Sr. Scientist, LC-MS/MS Bioanalysis – Hamden, CT, USA
                                                  • Associate Scientist, Central Laboratory Services
                                                  • Sr. Scientist - Pharmacokinetics (PK) Studies
                                                  • Content Manager, Scientific and Regulatory Writing

                                                Resources

                                                • Learning Center
                                                  • Blog
                                                    • Case Study
                                                      • News and Events
                                                        • Testimonials
                                                          • Contact Us

                                                            Request Quote

                                                              Contact Us

                                                              NorthEast BioLab Logo Agile Bioanalysis Services CRO
                                                              Request Quote Contact Us
                                                              • Home
                                                              • ELISA Method Development, Validation, And Testing Lab Services

                                                              Pioneering ELISA Method Development Validation Lab Services For Your PK, Biomarker, Or ADA Assay!

                                                              • Reproducible Sandwich and Competitive ELISA Lab Services For Quantitating Antibody, Protein, Peptide, Small Molecule, Etc
                                                              • Unmatched Turnaround For GLP ELISA Method Development Validation (Inc., Luminescence, TR-FRET, AlphaLISA, etc.)
                                                              • FDA Audited, Tailor-Made ELISA Validation Services On Multimode Plate Readers For Biomarkers, Biologics, As Well As Cell And Gene Therapies
                                                              • Cost-Effective ELISA Services Using Proprietary/Commercial Antibodies And Research Use (RUO) Kits For 1,000+ Antigens
                                                              Good Laboratory Practice for Nonclinical Laboratory StudiesFood and Drug Administration (FDA)

                                                              Provide Your Bioanalysis Study Details

                                                              We Will Contact You Within 1 Business Day

                                                              Click below for answers to your ELISA Method questions -
                                                              • What is Enzyme Linked Immunosorbent Assay (ELISA) Method?
                                                                What is Enzyme Linked Immunosorbent Assay (ELISA) Method?
                                                              • What is ELISA Method Development?
                                                                What is ELISA Method Development?
                                                              • Which ELISA Method Development do we Offer?
                                                                Which ELISA Method Development do we Offer?
                                                              • Why Choose us for your ELISA Method?
                                                                Why Choose us for your ELISA Method?

                                                              FDA Audited ELISA Method Development Validation Services!

                                                              • ELISA Lab Method Development And Validation As Per FDA Guidance On Ligand Binding Assay (LBA)
                                                              • Research Mode Or GLP ELISA Lab Services For Colorimetric, Fluorometric, Screening, Confirmation, Titration Assay, Etc
                                                              • Preclinical/Clinical ELISA Method Services For PD Biomarkers And Mechanism-Of-Action Studies
                                                              • Tailor-Made, High-Value ELISA Services In Various Biological Matrices For Small Medium Biotech
                                                              SPEAK TO OUR SCIENTISTS

                                                              What is Enzyme Linked Immunosorbent (ELISA) Method?

                                                              ELISA Method: Accurate and Flexible Analysis in 96 well plates

                                                              Enzyme Linked Immunosorbent Assay (ELISA) method is a widely utilized immunoassay for quantitating and detecting proteins, hormones, peptides, cytokines, antibodies, and other drugs along with their metabolites. ELISA methods are effective in quantitatively detecting any molecule, or antigen, that can be ascertained by an antibody. For example, ELISA methods are used in pregnancy testing, infectious disease identification, and detection of cytokines, and soluble receptor proteins, etc. Due to the precision, sensitivity, assay speed, and ease of quantitation, ELISA method development is a common choice for several diagnostic and research applications.

                                                              While there are various formats of ELISA method, the most common is a sandwich ELISA method. In this format, the analyte whose concentration is to be measured is sandwiched in-between two antibodies that bind to a different region (epitopes) on the antigen. These antibodies are referred to as detection antibody and capture antibody. In this assay, the capture antibody is coated to a microtiter plate in a 96-well format. The antigen binds to the capture antibody, and a detection antibody is used to measure the analyte. The antibody is conjugated to an enzyme, typically horseradish peroxidase (HRP), and detected via catalysis of a substrate which yields a colored product. Spectrophotometry is used to monitor the colored product, and a standard curve is utilized for calculating the antigen concentration in the sample. When the antigen is small, or two antibodies that can simultaneously bind to the antigen are unavailable, then another variation of ELISA, termed competitive ELISA method is utilized using a single epitope.

                                                              It is notable that the ELISA method typically uses 96 microwell plates for parallel analysis of many samples, standards, and controls in a single experiment. The surface of these plates is treated with special absorbents such that the antigen or antibody can adhere properly. ELISA method offers increased sensitivity and specificity compared to other standard antibody-based assays. In ELISA method, the interactions with analyte or antibody occur through serial binding that is done to some solid surface such as polystyrene in the 96 microwell plates discussed above.

                                                              What Our Sponsors Have to Say?

                                                              VP, Bioanalytical Development

                                                              NorthEast BioLab is by far the most responsive and thorough bioanalysis lab services CRO.

                                                              VP, Biomarker Development 

                                                              We partnered on several programs and found NorthEast BioLab responsive, collaborative, and reliable.

                                                              Executive Director, Pharmacokinetics

                                                              We trust NorthEast BioLab to design and execute the most streamlined and impactful bioanalytical projects.

                                                              President & CSO, Biotech

                                                              We found their integrity as refreshing as readiness to provide creative scientific input and high-quality data.

                                                              Sr. Associate Director, Clinical Trials

                                                              We have worked with NorthEast BioLab for over ten years given their commitment to highest quality bioanalytical data.

                                                              Co-Founder, Biotech & University PI

                                                              NorthEast BioLab tremendously supported us in reproducing our critical lab discoveries for drug metabolism.

                                                              VP, PK PD Analysis

                                                              NorthEast BioLab always exceeds expectations on bioanalytical assay development, validation, and sample analysis.

                                                              Head, Bioanalytical Development

                                                              NorthEast BioLab truly goes that extra mile, and we hope to continue enjoying seminal interactions with them.

                                                              Sr.Director, Bioanalytical Development & QC

                                                              NorthEast BioLab presents a science-based, hands-on, no-frills approach on the latest bioanalytical platforms.

                                                              SVP Quality & Compliance, Biotech

                                                              We are thrilled to complete our bioanalytical studies with their top quality and incredibly responsive team.

                                                              Director, PK

                                                              We worked closely to implement the most efficient and cost-effective bioanalytical assay for our PK Studies.

                                                              VP, Head of Clinical Operations

                                                              Our projects with NorthEast BioLab include successful method development, validation, stability studies during Clinical Phase I – IV studies.

                                                              Executive Director, Drug Research

                                                              NorthEast BioLab provides critical insight, and are compliant with regulatory standards and industry best practices. We highly recommend them and look forward to working together again.

                                                              Director, Bioequivalence Testing

                                                              Our latest successful study was a pivotal bioequivalence study, where samples from a cross-over study with about 100 volunteers needed swift analysis.

                                                              Head, PK

                                                              This study, same as all other bioanalytical studies with NorthEast BioLab, was completed with top quality and reporting standard with incredible responsiveness.

                                                              VP, Development Operations

                                                              As a small company, our vendors are key members of our project teams. The scientists at NorthEast BioLab are technical experts, who produce high-quality data, on-time, and on-budget.

                                                              Ready To Take The First Step, Today?

                                                              Explore Our ELISA Assay Development, Validation, And Testing Services Lab CRO!
                                                              SPEAK TO OUR SCIENTISTS

                                                              What Is ELISA Method Development?

                                                              Step-by-step ELISA Method Development

                                                              Enzyme Linked Immunosorbent Assay or ELISA Method development is a complex task involving multiple sequential steps for the measurement of analyte concentration in a sample.

                                                              Plate Coating

                                                              Whenever an ELISA method is developed for any analyte, a surface attachment strategy is established first. Once the analyte is affixed to the surface of the plate, it is immobilized and helps with the sequential addition of other reagents and washing cycles in the next steps, without mixing. ELISA method is thus a solid-phase assay.

                                                              The process of immobilizing an antibody or antigen to the plate is essential, as the method of immobilization utilized is what determines the efficacy of the ELISA method. Many times, the immobilization may cause a conformational change in the analyte or antibody, preventing the detection antibody from binding. Thus, it is critical to immobilize the antibody or antigen while preserving its conformational structure.

                                                              Antibody and Antigen Pairs

                                                              The specificity and sensitivity of the assay are determined using a range of concentrations of antibody and/or antigen. The affinity of the detection antibody and sensitivity of the detection reagents corresponding to a specific antigen are principally responsible for defining the performance of an optimized ELISA method. Selection of the best capture and detection antibody is critical for effective assay development.

                                                              Detection

                                                              The antibodies which are labeled with an enzyme (detection antibodies) contribute to the signal output of this assay. Different types of enzymes can be utilized, such as alkaline phosphatase, horseradish peroxidase, etc., each of which produces a color upon reacting with their substrates. These colored products are detected with spectrophotometry, where the signal intensity is proportional to the amount of antigen in the microwell. Afterward, a standard curve along with positive and negative controls is used to quantify the amount of analyte within a given sample.

                                                              Biomarker Assay List

                                                              Biomarker research, discovery, and qualification are pivotal in modern drug development from demonstrating proof-of-concept (POC) to establishing drug safety and efficacy in the clinic…

                                                              Explore Our Biomarker List

                                                              Which ELISA Method Development Do We Offer?

                                                              Extensive ELISA Method Development by NorthEast BioLab

                                                              NorthEast BioLab offers various client-centric ELISA method development services.

                                                              Bioanalytical Assay Development and Validation

                                                              Proper ELISA method development and validation are critical for the accurate quantification of an analyte. NorthEast BioLab helps you select the right ELISA method format and develop a robust protocol for analysis. Our specialists optimize the assay by titrating various components to ensure accurate results.

                                                              Pharmacokinetics (PK) Studies

                                                              Our pharmacokinetic studies for quantitation of drug-responsive levels of a specific serum protein using ELISA method development allow accurate and reliable pharmacokinetic data to help regulate dosage regimens.

                                                              Toxicokinetic (TK) Studies

                                                              As in pharmacokinetic studies, an ELISA method can be used in toxicokinetic studies to quantitate a drug or compound when administered at high dosage. TK studies allow estimation of the level of toxicity that can be produced by these drug compounds.

                                                              Biomarker Testing

                                                              ELISA method is hugely popular as a fundamental, cost-effective technique that offers high precision and broad dynamic range in addition to specificity, selectivity, and reliability for biomarker testing and quantitation.

                                                              Immunogenicity Testing Assay

                                                              An ELISA method can be used for immunogenicity testing. These studies are carried out to assess how drug exposure induces an immune response in the body of humans or other animals. It further evaluates how anti-drug antibodies (ADA) can affect immunogenicity.

                                                              Cell-Based Assay

                                                              Our scientists help clients with the successful execution of cell-based assays to assess the toxicity of the compounds and ensure reliable drug manufacturing. For example, we perform cytotoxicity testing and mechanism of action (MOA) assay to understand the biochemical reactions triggered by drug compounds.

                                                              Registered And Inspected By Various Regulatory Agencies

                                                              Why Choose Us For Your ELISA Method?

                                                              Frictionless ELISA Method from scratch or validated Research Use Only (RUO) kits

                                                              At NorthEast BioLab, we ensure robust ELISA methods to quantify large molecule analytes such as biologics, proteins, and antibodies in your samples. As often as it takes, our veteran scientists with 30+ years experience discuss and study your ELISA method development and validation in depth. Our team continues without yielding until we have customized these assays per your requirement and satisfaction.

                                                              We encourage intensive collaboration between the client and our scientists for complete transparency throughout your study with us. NorthEast BioLab offers quick turnaround times, scalability, and flexibility, given our extensive experience with ELISA method development and a thorough understanding of the science behind it. We enable our clients to expedite drug approval through efficient assay development, validation, and optimization while maintaining 100% regulatory compliance.

                                                              ELISA Method, based on colorimetric or chemiluminescent reaction, is the best-in-class ligand binding assay (LBA) predominantly used for large molecule bioanalytical method development and sample analysis. Scientists and regulatory agencies widely trust the direct, indirect, sandwich, and competitive variants of ELISA Development and Method Validation for diverse PK, BA/BE, TK, Immunogenicity (ADA), and Biomarker testing. Our veteran team undertakes Enzyme Linked Immunosorbent Assay development from scratch using available antibodies, diluents, buffers, substrates, reagents, control matrices, as well as research use only (RUO) kits. NorthEast BioLab delivers research mode, and fully GLP validated ELISA Method and Assay Development at an unmatched turnaround and value to sponsors.

                                                              Questions On Our ELISA Assay Development, Validation, And Testing Lab CRO Services?

                                                              Our Experienced Scientists Are Ready To Help You, Today!
                                                              SPEAK TO OUR SCIENTISTS

                                                              Related FAQs

                                                              Answers to additional ELISA
                                                              Method questions popular among our potential clients.

                                                              What is Enzyme Linked Immunosorbent Assay (ELISA) Method Development?

                                                              ELISA Method is an abbreviation for enzyme-linked immunosorbent assay, also called enzyme immunoassays (EIA). The fundamental principle used in ELISA method development is the use of antibodies to detect and quantify proteins, peptides, hormones, or other small molecules in preclinical or clinical samples. In an ELISA method development, antigens are immobilized on solid support either directly or via the use of a capture antibody immobilized on the surface. Subsequently, we add a primary detection antibody. If the detection antibody binds to the analyte of interest, the complex can be directly detected and quantified by the chromogenic tag or a secondary enzyme-conjugated antibody. In our GLP ELISA lab, we typically perform method development, validation, and sample analysis in multi-well plates (96- or 384-wells) for capture antigen binding. This characteristic makes the ELISA assay easy to perform on multiple samples simultaneously with excellent selectivity.

                                                              What are the various types of ELISA methods?

                                                              ELISA methods include a direct, indirect, sandwich, and competitive variants. In the direct ELISA method, an antigen is immobilized to the surface of a multi-well plate and detected with an antigen-specific antibody directly conjugated to HRP or another detection tag.

                                                              For an indirect ELISA assay, as with the direct ELISA method, an antigen is immobilized to the surface of the multi-well plate, but we need a two-step process for detection. The primary antibody binds to the antigen of interest, and then a secondary antibody labeled with a detection reagent is used for quantification. The sandwich ELISA method, the most widely used format, requires an antibody pair where each antibody is specific to a different epitope of the antigen. The first antibody, often called the capture antibody, is coated on the 96 well plate and binds to the analyte of interest. Once the unbound materials in the sample matrix get washed away, the second antibody conjugated with a detection tag quantitates the analyte. Competitive ELISA methods, often referred to as an inhibition ELISA assay or competitive immunoassays, measure the concentration of an antigen by detecting signal interference. We can adapt direct, indirect, or sandwich ELISA to the competitive format. Here, the antigen in the sample competes with a reference antigen pre-coated on a multi-well plate or added in the same plate wells. Consequently, lower concentrations of analyte produce a higher level of the signal. Some competitive ELISA assay, however, utilize a slightly different approach. These kits substitute a labeled antigen for the labeled antibody, but the principle of the assay remains the same.

                                                              Why is Sandwich ELISA method more sensitive?

                                                              In the Sandwich ELISA method, the specificity and selectivity offered by matched antibody pairs provide improved sensitivity and broad dynamic range. These ELISA assays require two antibodies, attaching with different epitopes on the same antigen, making them suitable for accurately isolating and quantitating antigens of interest within complex biological matrices such as plasma, serum, CSF, tissue lysates, etc. Furthermore, sandwich ELISA method development and validation are highly adaptable. We can optimize various assay conditions for the antibody pairs (e.g., type of assay plates, coating/washing/dilution buffer, coating-detection concentration, calibration standard/quality control/sample preparation, incubation times, etc.) to meet/exceed our immunoassay validation and sample analysis acceptance criteria. One of the most significant challenges faced by sponsor or ELISA Lab working on sandwich ELISA method is narrowing down a proprietary/commercially available antibody pair that works well together for desired assay parameters.

                                                              What is the difference between Direct ELISA vs. Indirect ELISA method?

                                                              In our GLP ELISA Lab, we perform both direct and indirect ELISA method development that differ in their means of detection. In the direct ELISA assay, an antigen is immobilized to the surface of a multi-well plate and detected with an antigen-specific antibody directly conjugated to HRP or other detection molecules. For an indirect ELISA assay, as with the direct ELISA method, the antigen is immobilized to the surface of the multi-well plate, but we need a two-step process for detection. The primary antibody binds to the analyte of interest and the secondary antibody labeled with the detection agent is used for quantitation. Direct ELISA methods are simple to set up and have no cross-reactivity from a secondary antibody but may have poor sensitivity due to high background as all proteins in the sample bind the well surface and there is no signal amplification to read the antigen. Indirect ELISA methods offer signal amplification to improve sensitivity but are more challenging to set up and perform and may have cross-reactivity from the secondary antibody.

                                                              What are the advantages of i) Direct ELISA, ii) Indirect ELISA, iii) Sandwich ELISA, and iv) Competitive ELISA?

                                                              The principle of ELISA involves antigen detection via binding to specific antibodies that we can apply in various formats. Direct ELISA method offers the advantages of easy experimental setup and execution, saving on time and reagent costs, and minimize concerns around cross-reactivity since there is no secondary antibody. Disadvantages of the direct ELISA method are the potential for high background due to all proteins in the sample binding the plate. Also, the primary antibody must be conjugated, and there is no signal amplification for analyte detection.

                                                              Indirect ELISA methods allow for signal amplification since multiple secondary antibodies can bind to the primary antibody. Indirect methods are also adaptable, allowing us to use the same secondary antibody for several primary antibodies. Disadvantages of an indirect ELISA method are potential cross-reactivity to the secondary antibody and higher time and cost needs relative to the direct ELISA method.

                                                              Sandwich ELISA methods offer excellent specificity as they employ two distinct antibodies for capture and detection. These ELISA, however, can be difficult to develop since discovering two antibodies that recognize two different epitopes on the same target and work well together can at times be difficult.

                                                              We can modify any ELISA method to a competitive format with a reference antigen and appropriate detection. Our team often employs Competitive ELISA to detect and quantitate low molecular weight antigens, such as small molecule drug compounds (e.g., Gentamicin).

                                                              What are the critical applications of ELISA Method?

                                                              ELISA labs perform sensitive and selective quantitation of various antigens during drug discovery and development. We rely on ELISA method development to evaluate pharmacokinetics (PK) or anti-drug antibody (ADA) for novel biological treatments and determine biomarkers predictive of preclinical or clinical disease, therapeutic treatment, or toxicity adverse events. In summary, our ELISA labs and assay kit vendor ecosystem can be immensely advantageous to your bioanalytical method development and validation. For many of your drug R&D assays, we can optimize commercial ELISA kits for performance, selectivity, sensitivity, and are adaptability to multiple biological sample matrices.

                                                              How do we perform ELISA method validation?

                                                              Enzyme-linked immunosorbent assay (ELISA) method validation should be fit for purpose and follow the FDA Bioanalytical Method Validation Guidance for Industry (May, 2018), specifically related to ligand binding assays (LBAs). Generally, ELISA method validation includes –

                                                              • All applicable experiments for Stock Solutions, Reference Standards, Quality Controls, Calibration Curve, Minimum Required Dilution, Spike Recovery, etc
                                                              • Six independent validation runs over multiple days for estimating Intraday and Intraday Accuracy and Precision
                                                              • Applicable experiments for Method Selectivity, Specificity, Matrix Effect, Matrix Suppression, etc.
                                                              • Process Stability experiments for Short-term Bench-Top, Freeze-Thaw, and Long-Term Cycles

                                                              How is ELISA method influenced by antibodies, blocking, diluents, washing, etc.?

                                                              ELISA Labs perform method development and validation for your analyte of interest as per assay requirements such as calibration range and limitations such as antibody pair affinity, minimum required dilution, observed background, etc. In sandwich ELISA methods, the antibodies selected for capture and detection must bind to two distinct epitopes of the antigen and work well to achieve the quantitative assay goals. Also, we must choose appropriate plate binding surfaces, assay blockers, and buffers for diluents and washing to suit the sample matrix and yield selective and sensitive quantitation. Furthermore, we need to carefully optimize antibody and sample concentration and incubation times for ELISA method development and validation. Among other factors, our scientists pay close attention to signal-to-noise (SNR) ratio, false-positive due to endogenous compounds, interference from endogenous or exogenous compounds, substrate selection, etc., for enhancing your ELISA method’s sensitivity, selectivity, specificity, and dynamic range.

                                                              How is ELISA method affected by plate readers, pipetting, and equipment handling by lab personnel?

                                                              ELISA methods, like any other highly sensitive bioanalytical quantitation, should be handled with care and precision. To begin with, we must review proper calibration and verification of instrumentation, pipettes, and other equipment before use. Next, we must intensively train all ELISA lab personnel in protocol reproducibility, pipetting techniques, and pipette tip handling to perform ELISA Method Development and Validation. Generally, ELISA method plate readouts and incubation steps are highly time-dependent. Thus, we must emphasize that plates must be analyzed quickly following the addition of substrate for any pre-reads or final reads after stopping the reaction. We can automate sample analysis for ELISA methods with liquid handlers, plate washers, and other robotics adaptable to 96- or 384-well plates.

                                                              What are the significant limitations of an ELISA method?

                                                              ELISA methods and enzyme immunoassays are valuable tools for analyzing large molecule antigens, proteins, and antibodies but are not suitable for all small molecules and alternate biomolecules. For proper execution, ELISA assays must include reasonable incubation times, appropriate binding of antibodies to the intended epitopes for capture and detection, compatible buffers, and a suitable level of plate washing. Furthermore, ELISA methods do not generally include an internal standard (IS) as in chromatographic assays. That said, we may use a visible dye in the plate reader’s detection range to track dilutions throughout the assay as a surrogate ELISA IS to verify that your ELISA Lab properly executes the assay steps and dilutions.

                                                              How long does an ELISA method take?

                                                              Generally, our ELISA lab can perform sample analysis from 2-to-4 96-well plates within a typical workday if we have ELISA method development and validation completed already. That said, sample preparation can vary per the complexity of the biological matrix and ELISA assay itself (e.g., tissues or whole cells vs. serum). Similarly, sample incubation times can vary, typically overnight or less. Our scientists closely monitor and control the incubation and readout times during ELISA Method Development and sample analysis for consistency in your ELISA assay results. Since the ELISA method readouts are enzyme-dependent, lab personnel should read plates in the optimal reaction time window as the signal can decay markedly over time.

                                                              How does the ELISA method for anti-drug antibodies work?

                                                              Our GLP ELISA lab regularly performs immunogenicity studies that look for the potential immune response to therapeutic agents as needed for clinical drug studies. A bridging enzyme linked immunosorbent assay is one of the most common methods to test for the presence and quantification of these anti-drug antibodies (ADA). In this sandwich ELISA method development, a biotinylated drug compound gets attached to the streptavidin coated ELISA plate, and another labeled drug compound gets utilized as a detection agent. Ultimately, the anti-drug antibody of interest bridges these drug compounds together. Among other antibodies, this ELISA method gets frequently used for IgG ADA detection.

                                                              Can ELISA method be used for quantitative purposes?

                                                              ELISA methods and other types of enzyme immunoassays are typically used to quantitate large molecules in biological matrices with excellent sensitivity and specificity. It can be quite challenging to develop an ELISA method for a novel biologic molecule in-house. Thus, you would be in the superb company of pioneering biotech to rely on our ELISA lab to characterize your drug pharmacokinetics or its correlation to pharmacodynamic responses related to efficacy or toxicity. Generally, proper ELISA lab method development offers versatility and utility for biomarker determinations in relation to disease states and disease treatment and modulation. As with any other quantitative bioanalytical method, ELISA assay should be fully validated or at least partially qualified before use as appropriate to your study objectives.

                                                              How do you use Research Use Only (RUO) ELISA Method Kits?

                                                              Research use only (RUO) label indicates in vitro diagnostic (IVD) products that can be used in the laboratory research phase of development. RUO ELISA kits are helpful for early drug discovery or preliminary diagnostic testing analyses but are not yet fully validated for compliance under GLP or clinical regulations. Commercially available RUO kits for ELISA lab protocols are typically qualified to some degree to ensure specificity, accuracy, and precision. Still, we need to fully validate these kits for the stability of test articles and critical reagents, cross-reactivity, or matrix interference. RUO ELISA procedures can be validated if the need arises, typically for novel biologic therapeutics reaching the preclinical toxicology phase or for novel clinical biomarkers of disease or therapy.

                                                              How is Enzyme Linked Fluorescent Assay (ELFA) different from Enzyme Linked Immunosorbent Assay (ELISA)?

                                                              Enzyme linked fluorescent assay (ELFA) is a similar enzyme immunoassay that uses the same principles as the ELISA assay but differs in the sample detection method. We use a fluorogenic substrate for detection in the ELFA assay instead of the chromogenic substrates used in ELISA assays. In general, ELFA is more sensitive than ELISA, making it helpful in detecting antigen biomarkers in earlier time windows relative to exposure for diagnostic disease testing.

                                                              Explore More Expertise

                                                              • Liquid Chromatography Mass Spectrometry Liquid Chromatography Mass
                                                                Spectrometry
                                                              • MSD ECL Assay MSD ECL
                                                                Assay
                                                              • Luminex Multiplex Assay Luminex Multiplex
                                                                Assay
                                                              • LI-COR Odyssey Assay LI-COR Odyssey
                                                                Assay
                                                              • PK PD Analysis PK PD
                                                                Analysis
                                                              • Method Development, Validation, and Transfer Method Development,
                                                                Validation, and Transfer

                                                              Expertise

                                                              • Liquid Chromatography Mass Spectrometry
                                                              • ELISA Method
                                                              • Meso Scale Discovery Assay
                                                              • Luminex Multiplex Assay
                                                              • LI-COR Odyssey Assay
                                                              • PK PD Analysis
                                                              • Method Development Validation and Transfer

                                                              Services

                                                              • Pharmacokinetics (PK) Study
                                                              • Toxicology (Tox) Study
                                                              • ADA Assay Immunogenicity Testing
                                                              • Biomarker Testing Services
                                                              • Bioequivalence and Bioavailability Studies
                                                              • Bioanalytical Assay

                                                              Solutions

                                                              • Bioanalysis
                                                              • GLP Laboratory
                                                              • Clinical CRO
                                                              • Preclinical CRO
                                                              • Analytical Testing
                                                              • Non-GLP Testing

                                                              About Us

                                                              • Overview
                                                              • Why Us?
                                                              • Values
                                                              • Leadership
                                                              • Process
                                                              • Quality and Compliance
                                                              • Facility and Equipment
                                                              • Therapeutic Areas
                                                              • Partners
                                                              • Careers

                                                              Resources

                                                              • Learning Center
                                                              • Blog
                                                              • Case Study
                                                              • News and Events
                                                              • Testimonials
                                                              • Contact Us
                                                              NorthEast BioLab Logo

                                                              35 Worth Ave, Hamden, CT 06518

                                                              sales@nebiolab.com
                                                              (203) 361 3780

                                                              Consult with a Scientist Now

                                                              We Will Contact You Within 1 Business Day

                                                              • Good Laboratory Practice for Nonclinical Laboratory Studies
                                                              • Food and Drug Administration (FDA)
                                                              • United States Drug Enforcement Administration
                                                              • Connecticut State Department of Consumer Protection
                                                              • Privacy Policy
                                                              • Terms of Use
                                                              • Sitemap
                                                              © 2019 - 2025, NorthEast BioAnalytical Laboratories LLC. All rights reserved.

                                                              How Can We Help?

                                                              I agree to receive emails, calls, and messages, etc from NorthEast BioLab.

                                                              Before you go! Get
                                                              your FREE Download:

                                                              Top 7 Hidden Pitfalls to your Bioanalytical Milestones

                                                              Step by step guide on how to accelerate your drug approval

                                                              • Addressing Main Constraints
                                                              • Research Best Practices
                                                              • The Economic Advantage
                                                              • Critical Decision Marketing Mode Easy
                                                              • Legal Documentation Checklist
                                                              We won’t share your email, ever, See our privacy policy

                                                              No thanks, I don’t need to improve my drug approval process